Rising Vitamin K Shot Refusals Raise New Concerns for Newborn Health

A growing number of parents in the United States are declining vitamin K injections for their newborn babies, prompting concern among pediatricians and other healthcare professionals who fear that misinformation and declining confidence in public health recommendations could put more infants at risk.

Newly reported health data indicates that the number of newborns who do not receive the vitamin K injection shortly after birth increased substantially during the first half of 2026. The trend has attracted renewed attention because vitamin K plays an important role in helping the blood clot, while newborn babies naturally have very small amounts of the vitamin.

Vitamin K refusals increase sharply

An analysis conducted by health analytics company Truveta examined medical records involving more than one million births between 2019 and June 2026. According to the analysis, the proportion of newborns who did not receive vitamin K within their first day of life reached 8.1 percent by the end of June.

That compares with approximately 5.2 percent six months earlier, representing an increase of more than 57 percent.

The analysis also found that the refusal rate during the first half of 2026 was considerably higher than the average recorded between 2019 and 2024. It was also significantly above the rate recorded in 2025.

Although parents declining the injection is not an entirely new phenomenon, doctors say the speed of the recent increase is particularly troubling.

Pediatric specialists interviewed for the original report described the development as part of a wider challenge involving declining confidence in vaccines, medicines and other standard medical interventions.

Why vitamin K matters to newborns

Vitamin K is essential for normal blood clotting. Babies are naturally born with relatively low levels of the vitamin, meaning they can be vulnerable to a rare but potentially devastating condition known as vitamin K deficiency bleeding.

The condition can cause bleeding in different parts of the body. In severe cases, bleeding can occur in the brain or digestive system and may result in permanent neurological damage or death.

The Centers for Disease Control and Prevention continues to recommend that newborns receive a vitamin K injection shortly after birth.

According to information cited in the original reporting, infants who do not receive the injection face a dramatically higher risk of serious vitamin K deficiency bleeding during their first months of life.

The concern among pediatricians is therefore not simply about whether parents accept one routine hospital procedure. They say the decision can have consequences that may not become apparent until a medical emergency occurs.

Doctors describe the human cost

For some physicians, concerns about declining vitamin K uptake are based on experiences they witnessed earlier in their careers.

One neonatologist recalled treating a baby during a cluster of vitamin K deficiency bleeding cases in Nashville more than a decade ago. The infant survived but was left with significant brain damage.

Such experiences have stayed with doctors who now worry that similar cases could become more common if refusal rates continue to rise.

Medical professionals emphasize that severe bleeding caused by vitamin K deficiency is preventable in the overwhelming majority of cases when newborns receive the recommended injection.

That makes the increase in refusals particularly difficult for clinicians who have seen the consequences firsthand.

The wider debate over public health messaging

The increase comes amid a broader political and cultural debate over vaccines and medical recommendations in the United States.

Health Secretary Robert F. Kennedy Jr. has spent years questioning aspects of mainstream vaccine policy and has promoted positions that have frequently placed him at odds with medical organizations and public health experts.

Earlier this year, changes to recommendations involving several childhood vaccines generated significant controversy. Some of those changes were subsequently challenged in court, while President Donald Trump later renewed calls for changes to childhood immunization policy.

Medical experts interviewed in the original report believe that these conflicting messages may contribute to uncertainty among some parents.

They argue that when government leaders publicly challenge established medical recommendations, parents may begin questioning other routine interventions, even when those interventions involve different medicines or preventive treatments.

Kennedy has rejected the suggestion that his policies are responsible for the increase in vitamin K refusals.

A spokesperson for the US Department of Health and Human Services also argued that distrust in public health institutions existed before the current administration and intensified during the COVID-19 pandemic.

The department said it is reviewing surveillance and other data concerning vitamin K refusals and bleeding incidents while continuing to provide information to parents and healthcare professionals.

Girls appear to have higher refusal rates

Another finding from the data has attracted attention among pediatric researchers.

The refusal rate appears to be higher among newborn girls than boys.

By June 2026, the analysis found that approximately 8.9 percent of girls had not received the vitamin K injection within a day of birth, compared with 7.3 percent of boys.

Researchers say the difference deserves further investigation.

Some doctors have observed that parents who are reluctant to accept vitamin K for their newborn sons may nevertheless want their children to undergo circumcision. Because vitamin K helps reduce the risk of bleeding, some hospitals will not perform circumcision when parents have declined the injection.

This may create a situation in which parents reconsider their decision because of the planned procedure.

Doctors say there is no equivalent surgical factor influencing decisions for most newborn girls, potentially contributing to the difference in refusal rates.

Researchers are now considering additional studies to understand why the gender gap exists.

Hospitals are adapting

Some healthcare providers are already changing their practices in response to the growing number of refusals.

One pediatric healthcare organization has begun ensuring that vitamin K is available at its primary care clinics so that infants who did not receive it in hospital can potentially receive it later.

Doctors say this approach reflects the reality that some parents may change their minds after leaving the hospital or may become more receptive to the treatment after discussing its purpose with their child's pediatrician.

Healthcare professionals generally recommend that parents discuss questions about vitamin K with their obstetrician, pediatrician or newborn care team before delivery.

They say parents should have an opportunity to understand both the benefits of the injection and the potential consequences of declining it.

A growing challenge for doctors

The debate surrounding vitamin K is ultimately part of a much larger question about trust in medicine.

Parents are increasingly exposed to conflicting information through social media, political discussions and online communities. For healthcare professionals, the challenge is to explain complicated medical evidence in a way that is understandable without dismissing legitimate questions from families.

Doctors say respectful communication is particularly important when discussing newborn care because decisions are often being made within hours of delivery.

The latest data does not prove that political messaging alone caused the increase in vitamin K refusals. Other factors, including long-standing distrust of medical institutions and experiences during the COVID-19 pandemic, may also play a role.

However, pediatric specialists warn that continued declines in vitamin K administration could eventually lead to more preventable cases of serious bleeding.

For families preparing for a baby's arrival, physicians say the safest approach is to discuss newborn medications and preventive treatments before delivery, understand the evidence behind them, and make decisions with qualified healthcare professionals rather than relying solely on information circulating online.

Source

The Independent, drawing on data analysis from Truveta, comments from pediatric specialists, and information from the US Centers for Disease Control and Prevention and the US Department of Health and Human Services.

Disclaimer: This article is intended for general informational purposes only. It is not medical advice and should not replace guidance from a qualified doctor, pediatrician, midwife, or other healthcare professional. Parents and caregivers should discuss vitamin K and other newborn treatments with their healthcare team before making decisions about their baby's care.